Rep. Val T. Hoyle Sells CVS Health Corporation (NYSE:CVS) Shares

Key Points

• Representative Val T. Hoyle sold between $1,001 and $15,000 in shares of CVS Health Corporation on September 23rd, 2025, as disclosed in a filing on October 10th.
• CVS Health's shares recently opened at $77.89 and have seen a 1.5% increase, with analysts projecting a consensus price target of $79.80.
• The company also declared a quarterly dividend of $0.665 per share, which will be paid on November 3rd, representing a 3.4% yield.

Representative Val T. Hoyle (D-Oregon) recently sold shares of CVS Health Corporation NYSE: CVS. In a filing disclosed on October 10th, the Representative disclosed that they had sold between $1,001 and $15,000 in CVS Health stock on September 23rd. The trade occurred in the Representative's "FIDELITY ROLLOVER IRA" account.

Representative Val T. Hoyle also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Marriott International NASDAQ: MAR on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Transdigm Group NYSE: TDG on 9/23/2025.
• Sold $1,001 - $15,000 in shares of H&R Block NYSE: HRB on 9/23/2025.
• Sold $1,001 - $15,000 in shares of NIKE NYSE: NKE on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Bank of New York Mellon NYSE: BK on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Cisco Systems NASDAQ: CSCO on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Capital One Financial NYSE: COF on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Pentair NYSE: PNR on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Heico NYSE: HEI.A on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Target NYSE: TGT on 9/23/2025.

CVS Health Stock Up 1.5%

Shares of NYSE:CVS opened at $77.89 on Friday. The firm has a fifty day moving average price of $72.28 and a two-hundred day moving average price of $67.67. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62. CVS Health Corporation has a one year low of $43.56 and a one year high of $79.20. The company has a market cap of $98.79 billion, a price-to-earnings ratio of 21.76, a PEG ratio of 0.85 and a beta of 0.60.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, beating the consensus estimate of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. During the same period last year, the firm earned $1.83 EPS. The business's quarterly revenue was up 8.4% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd will be issued a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.4%. The ex-dividend date of this dividend is Thursday, October 23rd. CVS Health's dividend payout ratio (DPR) is presently 74.30%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Farther Finance Advisors LLC lifted its holdings in CVS Health by 27.2% in the first quarter. Farther Finance Advisors LLC now owns 16,278 shares of the pharmacy operator's stock worth $1,107,000 after buying an additional 3,481 shares during the period. GAMMA Investing LLC lifted its holdings in CVS Health by 198.5% in the first quarter. GAMMA Investing LLC now owns 18,669 shares of the pharmacy operator's stock worth $1,265,000 after buying an additional 12,415 shares during the period. MV Capital Management Inc. increased its stake in shares of CVS Health by 63.9% during the first quarter. MV Capital Management Inc. now owns 741 shares of the pharmacy operator's stock valued at $50,000 after purchasing an additional 289 shares in the last quarter. Capital Advisors Ltd. LLC increased its stake in shares of CVS Health by 48.6% during the first quarter. Capital Advisors Ltd. LLC now owns 1,021 shares of the pharmacy operator's stock valued at $69,000 after purchasing an additional 334 shares in the last quarter. Finally, Simon Quick Advisors LLC bought a new position in shares of CVS Health during the first quarter valued at approximately $543,000. Institutional investors own 80.66% of the company's stock.

Analyst Upgrades and Downgrades

CVS has been the subject of several research reports. Wolfe Research upped their target price on shares of CVS Health from $80.00 to $85.00 and gave the stock an "outperform" rating in a research report on Monday, September 22nd. Mizuho upped their target price on shares of CVS Health from $76.00 to $88.00 and gave the stock an "outperform" rating in a research report on Thursday. Cantor Fitzgerald reiterated an "overweight" rating and issued a $78.00 target price on shares of CVS Health in a research report on Tuesday, August 26th. Bernstein Bank cut their target price on shares of CVS Health from $78.00 to $72.00 and set a "market perform" rating for the company in a research report on Wednesday, July 16th. Finally, Robert W. Baird raised shares of CVS Health from a "neutral" rating to an "outperform" rating and boosted their price target for the stock from $71.00 to $82.00 in a research note on Thursday, August 14th. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and four have issued a Hold rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $79.80.

Insider Buying and Selling at CVS Health

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the firm's stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the transaction, the director owned 22,156 shares of the company's stock, valued at approximately $1,573,519.12. This trade represents a 25.29% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.22% of the company's stock.

About Representative Hoyle

Val Hoyle (Democratic Party) is a member of the U.S. House, representing Oregon's 4th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. Hoyle (Democratic Party) is running for re-election to the U.S. House to represent Oregon's 4th Congressional District. She declared candidacy for the 2026 election. Val Hoyle was born in California and lives in Springfield, Oregon. Hoyle graduated from Merrimack High School. She earned a B.A. in political science from Emmanuel College in 1992. Her career experience includes working as a director at United Way of Lane County, a policy fellow at Wayne Morse Center for Law and Politics, and a commissioner at the Oregon Bureau of Labor and Industries. Hoyle has also worked in domestic and international sales, as well as manufacturing distribution.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.